CS
WST icon

Comerica Securities’s West Pharmaceutical WST Stock Holding History

Comerica Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-168
Closed -$39.5K – 1421
2022
Q4 		$39.5K Buy
+168
New +$39.8K ﹤0.01% 774
2022
Q3 		– Sell
-711
Closed -$215K – 476
2022
Q2 		$215K Sell
711
-492
-41% -$160K 0.02% 448
2022
Q1 		$494K Buy
1,203
+60
+5% +$23.5K 0.03% 313
2021
Q4 		$536K Buy
1,143
+39
+4% +$16.8K 0.03% 311
2021
Q3 		$469K Sell
1,104
-271
-20% -$114K 0.03% 321
2021
Q2 		$494K Sell
1,375
-505
-27% -$167K 0.04% 314
2021
Q1 		$530K Buy
1,880
+7
+0.4% +$2K 0.04% 307
2020
Q4 		$531K Sell
1,873
-124
-6% -$34.8K 0.04% 288
2020
Q3 		$549K Buy
1,997
+230
+13% +$60.9K 0.05% 261
2020
Q2 		$401K Sell
1,767
-244
-12% -$47.9K 0.04% 303
2020
Q1 		$306K Sell
2,011
-39
-2% -$6K 0.03% 311
2019
Q4 		$308K Sell
2,050
-213
-9% -$31K 0.03% 349
2019
Q3 		$321K Buy
2,263
+92
+4% +$12.7K 0.03% 337
2019
Q2 		$272K Sell
2,171
-172
-7% -$20.3K 0.03% 361
2019
Q1 		$258K Buy
2,343
+40
+2% +$4.16K 0.03% 369
2018
Q4 		$226K Buy
2,303
+8
+0.3% +$868 0.03% 367
2018
Q3 		$283K Buy
+2,295
New +$257K 0.03% 360

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Comerica Securities's WST Position: Q1 2023 in Review

Comerica Securities sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 168 shares — an estimated $39.5K sold.

Comerica Securities first reported a position in WST in Q3 2018 and held it in 17 quarters. The position peaked at $549K in Q3 2020. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Comerica Securities reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 168 West Pharmaceutical shares in Q1 2023, an estimated $39.5K.
  • Comerica Securities first reported a position in West Pharmaceutical in Q3 2018 and held it in 17 quarters.
  • Comerica Securities's West Pharmaceutical position peaked at $549K in Q3 2020.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.